Due to health issues, this site is no longer maintained and will be shut down shortly.

ADIL Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc is a United States-based pharmaceutical company. The company develops prescription medications for addiction and related disorders.

Their auditors issued a going concern opinion on their December 31, 2019 financial statements, expressing substantial doubt that they could continue as an ongoing business for the next twelve months.   

$0.35  -0.03 (-7.85%)
As of 03/24/2023 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  07/27/2018
Outstanding shares:  28,516,564
Average volume:  513,076
Market cap:   $10,899,031
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy